Last update 20 Mar 2025

GRAdHIVNE1 Vaccine(International AIDS Vaccine Initiative)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms
Gorilla Adenovirus Vectored Networked Epitopes Vaccine(International AIDS Vaccine Initiative), gorilla-isolated adenovirus (GRAd32) vector(International AIDS Vaccine Initiative)
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Immune System DiseasesInfectious DiseasesUrogenital Diseases
Active Indication
HIV Infections
Inactive Indication-
Originator Organization
International AIDS Vaccine Initiative, Inc.International AIDS Vaccine Initiative, Inc.
Active Organization
ReiThera SrlReiThera SrlInternational AIDS Vaccine Initiative, Inc.International AIDS Vaccine Initiative, Inc.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with GRAdHIVNE1 Vaccine(International AIDS Vaccine Initiative)
NCT06617091
/ Not yet recruitingPhase 1IIT
A Phase 1 Randomized Double Blinded Placebo Controlled, Dose Ranging Trial, of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without HIV and Living with HIV, in Southern Africa
100 Clinical Results associated with GRAdHIVNE1 Vaccine(International AIDS Vaccine Initiative)
Login to view more data
100 Translational Medicine associated with GRAdHIVNE1 Vaccine(International AIDS Vaccine Initiative)
Login to view more data
100 Patents (Medical) associated with GRAdHIVNE1 Vaccine(International AIDS Vaccine Initiative)
Login to view more data
100 Deals associated with GRAdHIVNE1 Vaccine(International AIDS Vaccine Initiative)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 1-
ReiThera SrlReiThera Srl
12 Feb 2025
HIV InfectionsPhase 1-
International AIDS Vaccine Initiative, Inc.International AIDS Vaccine Initiative, Inc.
12 Feb 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free